Pharming Income Statement (2019-2026) | PHAR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.05B	0.05B	-0.14B	0.05B	0.05B	0.05B	0.15B	0.04B	0.10B	0.07B	81.20	55.59	0.13B	74.80	204.50	79.09	172.32	0.10B	106.50	0.07B
Cost of Revenue (Quarter)	0.00B	0.01B	-0.01B	0.00B	0.05B	0.00B	0.02B	0.00B	5,700.00B	0.01B	0.03B	0.01B	0.02B	6.80	23,200.00B	8.32	0.02B	7,100.00B	21,100.00B	0.01B
Gross Profit (Quarter)	0.05B	0.05B	0.08B	0.04B	0.05B	0.05B	0.14B	0.04B	49,200.00B	0.06B	146,000.00B	47.20	0.11B	68.00	181.30	70.77	155.02	0.09B	85.40	0.07B
Operating items
Research & Development (Quarter)		-0.01B	0.04B			-0.01B	-0.05B	-0.02B	-0.04B	-0.02B	-57.30	-0.02B	-0.04B	-20.70	-0.08B	-0.02B	-0.04B	-23.40	-32.10	-0.03B
Selling, General & Administrative (Quarter)		-0.01B	0.02B			-0.01B	-0.03B	-0.01B	-11.00	-0.01B	-0.06B	-0.02B	-0.03B	-15.30	-46.00	-0.02B	-0.04B	-17.00	-20.00	-0.02B
Operating Expenses (Quarter)		-0.02B	0.06B			-0.02B	-0.08B	-0.03B	-0.04B	-0.03B	-0.06B	-0.03B	-0.07B	-36.00	-0.08B	-0.04B	-0.09B	-40.40	-52.10	-0.04B
Operating Income (Quarter)	0.01B	-0.00B	0.02B	0.00B	0.02B	0.01B	0.03B	-0.01B	5,300.00B	0.00B	-6.50	-16.31	-0.02B	0.00B	-0.01B	-7.04	3.81	0.02B	6.20	-0.00B
EBIT (Quarter)	0.01B	-0.00B	-0.01B	0.00B	0.02B	0.01B	0.03B	-0.01B	5,300.00B	0.00B	-6.50	-16.31	-0.02B	0.00B	-0.01B	-7.04	3.81	0.02B	6.20	-0.00B
Non-operating items
Non Operating Interest Expenses (Quarter)		-0.00B	0.00B			0.00B				-0.01B
Non Operating Investment Income (Quarter)		-0.00B	-0.00B				-0.00B				0.00B		0.01B	-0.00B	-0.20
Other Non Operating Income (Quarter)		-0.00B	0.00B			-0.00B	-0.01B	-0.00B	-0.01B	0.00B	-4.50	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	0.00B	-0.02B	-0.00B
Non Operating Income (Quarter)				0.00B				-0.00B	-0.00B	0.00B	-0.01B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.01B	0.00B	-0.01B	0.00B
Net income details
EBT (Quarter)	0.01B	-0.02B	0.01B	0.00B	0.02B	0.01B	0.03B	-0.01B	-0.01B	0.00B	-0.01B	-16.31	-0.02B	0.00B	-0.01B	-7.04	3.81	12.70	4.80	-0.00B
Tax Provisions (Quarter)	-0.00B	-0.00B	0.01B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-2.50	-0.00B	-0.00B	-0.01B	-5.20	-0.01B	-0.00B
Profit After Tax (Quarter)	0.01B	-0.00B	0.01B	0.00B	0.02B	-0.02B	0.01B	-0.02B	-0.02B	0.00B	-0.01B	-0.00B	-0.02B	0.00B	-0.01B	0.00B	0.01B	17.90	0.01B	-0.00B
Equity Income (Quarter)				0.00B				-0.01B
Income from Non-Controlling Interests (Quarter)										-0.00B	-0.00B			-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Income from Continuing Operations (Quarter)	0.01B	-0.02B	0.02B	0.00B	0.02B	0.01B	0.04B	-0.02B	-0.02B	0.00B	-0.01B	-0.00B	-0.02B	0.00B	-0.01B	0.00B	0.01B	17.90	0.01B	-0.00B
Consolidated Net Income (Quarter)	0.01B	-0.02B	0.02B	0.00B	0.02B	0.01B	0.04B	-0.02B	-0.02B	0.00B	-0.01B	-0.00B	-0.02B	0.00B	-0.01B	0.00B	0.01B	17.90	0.01B	-0.00B
Income towards Parent Company (Quarter)	0.01B	-0.02B	0.02B	0.00B	0.02B	0.01B	0.03B	-0.01B	1.30	0.00B	-7.40	-0.01B	-0.01B	-1.10	-0.01B	-0.01B	-0.01B	7.50	5.30	-0.01B
Net Income towards Common Stockholders (Quarter)	0.01B	-0.02B	0.02B	0.00B	0.02B	0.01B	0.03B	-0.01B	1.30	0.00B	-7.40	-0.01B	-0.01B	-1.10	-0.01B	-0.01B	-0.01B	7.50	5.30	-0.01B
Additional items
EPS (Basic) (Quarter)	0.02	-0.03	0.02	0.01	0.02	0.01	0.04	-0.02	0.00	0.01	0.00	-0.02	-0.02	0.00	-0.02	-0.02	-0.01	0.00	0.00	-0.01
EPS (Diluted) (Quarter)	0.02	-0.02	0.02	0.01	0.02	0.01	0.04	-0.02	0.00	0.00	0.00	-0.02	-0.02	0.00	-0.02	-0.02	-0.01	0.00	0.00	-0.01
Shares Outstanding (Quarter)	0.64B	0.64B	0.64B	0.64B	0.64B	0.66B	0.65B	0.65B	0.65B	0.65B	0.66B	0.66B	0.66B	0.66B	0.67B	0.67B	0.67B	0.67B	0.69B	0.69B
Shares Outstanding (Diluted) (Quarter)	0.76B	0.76B	0.70B	0.70B	0.78B	0.72B	0.71B	0.71B	0.71B	0.71B	0.73B	0.73B	0.73B	0.73B	0.79B	0.79B	0.79B	0.79B	0.75B	0.75B
EBITDA (Quarter)	0.01B	-0.00B	-0.01B	0.00B	0.02B	0.01B	0.03B	-0.01B	5,300.00B	0.00B	-6.50	-16.31	-0.02B	0.00B	-0.01B	-7.04	3.81	0.02B	6.20	-0.00B
Interest Expenses (Quarter)		-0.00B	0.00B			0.00B	0.00B		0.01B	-0.00B	0.01B			0.00B	0.01B				0.02B
Tax Rate (Quarter)	-12.64%	8.95%	55.29%	-28.57%	-21.28%	-2.15%	-14.50%	-32.69%	-18.05%	4.75%	-12.19%	-25,600,784.70%	-15.53%	0.00%	39.44%	44,009,085.75%	-147,936,925.10%	-40.94%	-214,791,666.67%	9.35%

Research Tools

Developers

Pharming Income Statement (2019-2026) | PHAR

Research Tools

Developers

Pharming Income Statement (2019-2026) | PHAR

Create an account

Sign In

Reset Password